md-medicaldata

Authors

 

Katarina Bačulov¹, ², Jelena Stojčević Maletić³, Jovana Drljača⁴, Iva Barjaktarović<sup>5

1</sup>Katedra opšteobrazovnih predmeta, Medicinski fakultet, Univerzitet u Novom Sadu
²Katedra za farmaciju, Medicinski fakultet, Univerzitet u Novom Sadu
³Katedra za biohemiju, Medicinski fakultet,Univerzitet u Novom Sadu
⁴Medicinski fakultet, Univerzitet u Novom Sadu
⁵Katedra opšteobrazovnih predmeta, Medicinski fakultet, Univerzitet u Novom Sadu

 

UDK: 616-005.6:575.224

The paper was received / Rad primljen: 24.02.2019.

Accepted / Rad prihvaćen: 05.03.2019.

 

Correspondence to:

Asist. Katarina Bačulov
Katedra opšteobrazovnih predmeta, Medicinski fakultet
Univerzitet u Novom Sadu,
e-mail: katarina.baculov@mf.uns.ac.rs

 

 

Sažetak

 

Uvod: Metiltetrahidrofolat redukatza (MTHFR) kodira istoimeni enzim odgovoran za metabolizam folne kiseline koja dalje učestvuje u metabolisanju homocisteina čiji poremećen nivo u krvi dovodi do nastanka kardiovaskularnih bolesti (KVB). Dva najčešća polimorfizma MTHFR gena su supstitucija citozina timinom na poziciji 677 (C677T) i zamena adenina citozinom na poziciji 1298 (A1298C). Cilj rada bio je da se utvrdi učestalost mutacija MTHFR C677T i MTHFR A1298C kod bolesnika sa trombozama. Materijal i metode: U istraživanje su bili uključeni pacijenti hospitalizovani u Kliničkom Centru Vojvodine zbog infarkta miokarda ili cerebrovaskularnog insulta čiji uzrok je formiranje trombocitnog čepa u krvnim sudovima. Svaki ispitanik je testiran na prisustvo MTHFR C677T i/ili MTHFR A298C mutacije pomoću real time PCR metode. Rezultati: Za MTHFR C677T mutaciju ustanovljeno je da je bilo 50% heterozigota, 40% homozigota za divlji tip alela, a učestalost homozigota za mutiran alel iznosila je svega 10%. Za MTHFR A1298C mutaciju utvrđena je učestalost heterozigota od 25%, homozigota za divlji tip gena 70%, a homozigota za mutirani alel samo 5%. Zaključak: U istraživanju je prikazano da je kod pacijenata sa nekim oblikom tromboze ili cerebralne hemoragije najviše zastupljen divlji tip alela za obe MTHFR mutacije, te uzrok njihove bolesti predstavljaju varijante nekih drugih gena koji su takođe važni za koagulaciju krvi.

 

 

Ključne reči:

MTHFR polimorfizam,  mutacija C677T, mutacija A1298C, infarkt miokarda, cerebrovaskularni insult

 

 

Abstract

 

Introduction: Methyltetrahydrofolate reductase (MTHFR) encodes the enzyme responsible for the metabolism of folic acid, which further participates in the metabolism of homocysteine and its disrupted level in the blood leads to the formation of cardiovascular diseases. The two most common polymorphisms of the MTHFR gene are the substitution of cytosine with thymine at position 677 (C677T) and the replacement of adenine with cytosine at position 1298 (A1298C). The main aim of this study was to determine the frequency of MTHFR C677T and MTHFR A1298C mutations in patients with thromboses. Material and Methods: In the research we included patients hospitalized at the Clinical Center of Vojvodina who suffered myocardial infarction or cerebrovascular insult due to the formation of a platelet plug in the blood vessels. Genotypes of MTHFR C677T and MTHFR A298C polymorphisms for each patient were determined using a real time PCR method. Results: For the MTHFR C677T polymorphism was found 50% heterozygous, 40% homozygous for wild type alleles, and the homozygous rate for mutated allele was only 10%. For the MTHFR A1298C mutation, it has been established that the heterozygote frequency is 25%, the homozygous for the wild type of gene is 70%, and the homozygous for mutated allele is only 5%. Conclusion: In this study, we found that the most common type of allele for both MTHFR mutations is wild type allele in patients with some form of thrombosis or cerebral hemorrhage, thus the cause of their disease may be the consequence of variant of some other genes that are also important for blood coagulation.

 

 

Key words:

MTHFR polymorphism, C677T mutation, A1298C mutation, myocardial infarction, cerebrovascular insult

 

 

 

References:

 

1. Rosenberg N, Murata M, Ikeda Y, Opare-Sem O, Zivelin A, Geffen E,et al. The Frequent 5,10-Methylenetetrahydrofolate Reductase C677T Polymorphism Is Associated with a Common Haplotype in Whites, Japanese, and Africans. Am J Hum Genet. 2002;70(3):758–762.
2. Xu J, Li K, Zhou W. Relationship between genetic polymorphism of MTHFR C677T and lower extremities deep venous thrombosis. Hematology 2019;24:108-111.
3. Đurović J. Analiza polimorfizama gena za receptor za vitamin D i gena asociranih sa trombofilijom kod žena sa idiopatskim infertilitetom [disertacija]. Beograd: Univerzitet u Beogradu, Biološki fakultet;2017.
4. Bagly PJ, Selhub J. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci U S A. 1998;95(22):13217–13220.
5. Krajinovic M, Lamothe S,  Labuda D,  Lemieux-Blanchard É, Théorêt Y, Moghrabi A et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 2004;103:252-257.
6. Baszczuk A, Kopczynski Z. Hyperhomocysteinemia in patients with cardiovascular disease [Abstract] Postepy Hig Med Dosw.2014;68:579.
7. Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14:6.
8. Levin BL, Varga E. MTHFR: Addressing Genetic Counseling Dilemmas Using Evidence-Based Literature. J Genet Couns. 2016;25(5):901-11.
9. Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey Sh, et al. A Common Mutation A1298C in Human Methylenetetrahydrofolate Reductase Gene: Association with Plasma Total Homocysteine and Folate Concentrations. Journal of Nutrition 1999;129: 1656-1661.
10. Hanson NQ, Aras Ö, Yang F, Tsai MY. C677T and A1298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease. Clinical Chemistry 2001;47:661-666.
11. Đorđević V, Rakićević Lj, Spasić M, Miljić P, Miković D, Kovač M et al.   Mutacije FV Leiden, FII G20210A i MTHFR C677T kao faktori rizika za nastanak tromboze dubokih vena u toku trudno_e ili puerperijuma. Vojnosanit Pregl 2005;62(3):201-205.
12. Yamada K, Chen Zh, Rozen R, Matthews RG. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. PNAS  2001;98(26):14853-14858.
13. Liu F, Silva D, Malone MV, Seetharaman K. MTHFR A1298C and C677T Polymorphisms Are Associated with Increased Risk of Venous Thromboembolism: A Retrospective Chart Review Study. Acta Haematol. 2017;138(4):208-215.
14. Ozmen F, Ozmen MM, Ozalp N, Akar N. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis. Ulus Travma Acil Cerrahi Derg. 2009;15(2):113-9.
15. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000;151(9):862-77.
16. Alam MA, Husain SA, Narang R, Chauhan SS, Kabra M, et al. Association of polymorphism in the thermolabile 5, 10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease. Mol Cell Biochem 2008; 310:111-117.
17. Alam MA. Methylenetetrahydrofolate Reductase Gene Polymorphisms and Cardiovascular Diseases. Cell Dev Biol 2016;5:2.
18. Spronk KJ, Olivero AD, Haw MP, Vettukattil JJ. Methylenetetrahydrofolate reductase C677T: hypoplastic left heart and thrombosis. World J Pediatr Congenit Heart Surg 2015;6:643-645.
19. Weisberg IS, Jacques PF, Selhub J, Bostom AG, Chen Z, et al. The 1298A—>C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis. 2001;156(2):409-15.
20. Brustolin S, Giugliani R, Félix TM. Genetics of homocysteine metabolism and associated disorders. Braz J Med Biol Res. 2010;43(1):1–7.

PDF Bačulov K. et al • MD-Medical Data 2019;11(1): 015-018